Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses

BACKGROUND: Nivolumab has changed the treatment of advanced gastric cancer (AGC). Nivolumab shows better outcomes compared to best supportive care among AGC patients who received at least two prior regimens. However, there are no reliable data regarding AGC patients with poor performance status (PS)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Matsumoto, Toshihiko, Yamamoto, Yosuke, Kuriona, Yusuke, Okazaki, Ukyo, Kimura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Mastumoto, Yusuke, Takatani, Masahiro
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376661/
https://ncbi.nlm.nih.gov/pubmed/32698781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07176-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares